E2F1 and breast cancer: We obtained similar results (Figure 3b–d) when E2F1 levels were compared with the breast cancer intrinsic subtypes [3], with the recurrence score [17] and with the wound response signature [7], all of these gene expression-based predictors being reported by Fan and colleagues in the NKI data set [8].